{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T22:23:49Z","timestamp":1786832629780,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.gim.2023.100945","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T02:26:04Z","timestamp":1690338364000},"page":"100945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Factors that differentiate cancer risk management decisions among females with pathogenic\/likely pathogenic variants in PALB2, CHEK2, and ATM"],"prefix":"10.1016","volume":"25","author":[{"given":"Marleah","family":"Dean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L.","family":"Tezak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Almanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuya","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-2857","authenticated-orcid":false,"given":"Deborah L.","family":"Cragun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gim.2023.100945_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10689-021-00251-3","article-title":"\u2018I wish that there was more info\u2019: characterizing the uncertainty experienced by carriers of pathogenic ATM and\/or CHEK2 variants","volume":"21","author":"Reyes","year":"2022","journal-title":"Fam Cancer"},{"issue":"7","key":"10.1016\/j.gim.2023.100945_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.gim.2023.100945_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.gim.2023.100945_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/gepi.21971","article-title":"Penetrance of ATM gene mutations in breast cancer: a meta-analysis of different measures of risk","volume":"40","author":"Marabelli","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"28","key":"10.1016\/j.gim.2023.100945_bib6","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","article-title":"Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer","volume":"29","author":"Cybulski","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.gim.2023.100945_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10897-016-9981-6","article-title":"Adherence to recommended risk management among unaffected women with a BRCA mutation","volume":"26","author":"Buchanan","year":"2017","journal-title":"J\u00a0Genet Couns"},{"issue":"1","key":"10.1016\/j.gim.2023.100945_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.a.33068","article-title":"The process of deciding about prophylactic surgery for breast and ovarian cancer: patient questions, uncertainties, and communication","volume":"152A","author":"Klitzman","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.gim.2023.100945_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10549-020-05699-y","article-title":"Cancer risk management among female BRCA1\/2, PALB2, CHEK2, and ATM carriers","volume":"182","author":"Cragun","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.gim.2023.100945_bib11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/00909882.2019.1657236","article-title":"Uncertainty and previvors\u2019 cancer risk management: understanding the decision-making process","volume":"47","author":"Dean","year":"2019","journal-title":"J\u00a0Appl Commun Res"},{"key":"10.1016\/j.gim.2023.100945_bib12","series-title":"Qualitative Research Methods: Collecting Evidence, Crafting Analysis, Communicating Impact","author":"Tracy","year":"2019"},{"key":"10.1016\/j.gim.2023.100945_bib13","unstructured":"Bernard H.R. Research Methods in Anthropology: Qualitative and Quantitative Approaches. 5th ed. Alta Mira Press; 2011. https:\/\/rowman.com\/isbn\/9781442268883\/research-methods-in-anthropology-qualitative-and-quantitative-approaches-sixth-edition"},{"issue":"1","key":"10.1016\/j.gim.2023.100945_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-020-01070-3","article-title":"Coincidence analysis: a new method for causal inference in implementation science","volume":"15","author":"Whitaker","year":"2020","journal-title":"Implement Sci"},{"issue":"2","key":"10.1016\/j.gim.2023.100945_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cncr.26294","article-title":"Long-term outcomes of BRCA1\/BRCA2 testing: risk reduction and surveillance","volume":"118","author":"Schwartz","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gim.2023.100945_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13058-017-0826-5","article-title":"Decision making for breast cancer prevention among women at elevated risk","volume":"19","author":"Padamsee","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.gim.2023.100945_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.a.20431","article-title":"Screening adherence in BRCA1\/2 families is associated with primary physicians\u2019 behavior","volume":"125A","author":"Tinley","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.gim.2023.100945_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/cncr.32572","article-title":"Clinical utility of hereditary cancer panel testing: impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations","volume":"126","author":"Vysotskaia","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.gim.2023.100945_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.socscimed.2016.06.039","article-title":"\u201cIt\u2019s not if I get cancer, it\u2019s when I get cancer\u201d: BRCA-positive patients\u2019 (un)certain health experiences regarding hereditary breast and ovarian cancer risk","volume":"163","author":"Dean","year":"2016","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.gim.2023.100945_bib20","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/pon.4686","article-title":"Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain","volume":"27","author":"Esteban","year":"2018","journal-title":"Psycho-Oncology"},{"issue":"4","key":"10.1016\/j.gim.2023.100945_bib21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1037\/a0014778","article-title":"Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review","volume":"28","author":"Hamilton","year":"2009","journal-title":"Health Psychol"},{"issue":"3","key":"10.1016\/j.gim.2023.100945_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.17730\/1938-3525-80.3.203","article-title":"Using an anthropological lens to explore motivators and challenges for follow-up care decision making among female BRCA1\/2 carriers at risk for inherited cancer","volume":"80","author":"Tezak","year":"2021","journal-title":"Hum Organ"},{"issue":"8","key":"10.1016\/j.gim.2023.100945_bib23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/pon.5679","article-title":"Exploring the effects of genomic testing on fear of cancer recurrence among breast cancer survivors","volume":"30","author":"Gormley","year":"2021","journal-title":"Psycho-Oncology"},{"issue":"4","key":"10.1016\/j.gim.2023.100945_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pon.4103","article-title":"Current state and future prospects of research on fear of cancer recurrence","volume":"26","author":"Lebel","year":"2017","journal-title":"Psycho-Oncology"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023009589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023009589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T20:43:04Z","timestamp":1730493784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360023009589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1098360023009589"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2023.100945","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors that differentiate cancer risk management decisions among females with pathogenic\/likely pathogenic variants in PALB2, CHEK2, and ATM","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2023.100945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100945"}}